EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone

Luis F de Castro, Zachary Michel, Kristen Pan, Jocelyn Taylor, Vivian Szymczuk, Sriram Paravastu, Babak Saboury iD, Georgios Z Papadakis, Xiaobai Li, Kelly Milligan, Brendan Boyce, Scott M Paul und 2 weitere

New England Journal of Medicine · 23.02.2023 · 388 (8) · 766-768

DOI: 10.1056/nejmc2214862 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 23.02.2023. Verfasst von Luis F de Castro und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health, Bethesda, MD. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Denosumab, Fibrous Dysplasia of Bone. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsDenosumabFibrous Dysplasia of BoneHumansTreatment Outcome

Substanzen

Bone Density Conservation AgentsDenosumab

Autor:innen und Institutionen

  • National Institutes of Health, Bethesda, MD.
  • Foundation for Research and Technology, Heraklion, Greece.
  • University of Rochester Medical Center, Rochester, NY.
  • National Institutes of Health, Bethesda, MD alison.boyce@nih.gov.

ORCID-Profile: Babak Saboury, Alison M Boyce

Förderung

  • Intramural NIH HHS
  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research
  • Amgen

Zitieren

APA

de Castro, L. F., Michel, Z., Pan, K., Taylor, J., Szymczuk, V., Paravastu, S., Saboury, B., Papadakis, G. Z., Li, X., Milligan, K., Boyce, B., Paul, S. M., Collins, M. T., & Boyce, A. M. (2023). Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. New England Journal of Medicine, 388(8), 766-768. https://doi.org/10.1056/nejmc2214862

Vancouver

de Castro LF, Michel Z, Pan K, Taylor J, Szymczuk V, Paravastu S, et al. Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. New England Journal of Medicine. 2023;388(8):766-768. doi:10.1056/nejmc2214862

BibTeX
@article{deCastro2023,
  author = {de Castro, Luis F and Michel, Zachary and Pan, Kristen and Taylor, Jocelyn and Szymczuk, Vivian and Paravastu, Sriram and Saboury, Babak and Papadakis, Georgios Z and Li, Xiaobai and Milligan, Kelly and Boyce, Brendan and Paul, Scott M and Collins, Michael T and Boyce, Alison M},
  title = {Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {8},
  pages = {766--768},
  doi = {10.1056/nejmc2214862}
}
Kostenlos starten →